GR1000419B - Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. - Google Patents
Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.Info
- Publication number
- GR1000419B GR1000419B GR900100015A GR900100015A GR1000419B GR 1000419 B GR1000419 B GR 1000419B GR 900100015 A GR900100015 A GR 900100015A GR 900100015 A GR900100015 A GR 900100015A GR 1000419 B GR1000419 B GR 1000419B
- Authority
- GR
- Greece
- Prior art keywords
- dosage form
- acalcium
- antagonist
- supply
- nicardipine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Αποκαλύπτεται μια μορφή δοσολογίας (10) περιλαμβάνουσα ένα μέλος που επιλέγεται από την ομάδα που αποτελείται από nicardipine και τα φαρμακευτικώς αποδεκτά άλατά της για χορήγηση σε έναν ασθενή που χριεάζεται καρδιοαγγειακή θεραπεία. ω
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30370689A | 1989-01-30 | 1989-01-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
GR900100015A GR900100015A (en) | 1991-06-07 |
GR1000419B true GR1000419B (el) | 1992-06-30 |
Family
ID=23173326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR900100015A GR1000419B (el) | 1989-01-30 | 1990-01-10 | Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0455648B1 (el) |
JP (1) | JPH04503058A (el) |
AU (1) | AU621182B2 (el) |
CA (1) | CA2007106A1 (el) |
DK (1) | DK23790A (el) |
ES (2) | ES2054333T3 (el) |
FI (1) | FI913608A0 (el) |
GR (1) | GR1000419B (el) |
IE (1) | IE61872B1 (el) |
PT (1) | PT92994B (el) |
WO (1) | WO1990008536A1 (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ238867A (en) * | 1990-07-12 | 1993-08-26 | Alza Corp | Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
PT1035834E (pt) * | 1997-12-05 | 2002-09-30 | Alza Corp | Forma de dosagem osmotica que compreende primeiro e segundo revestimentos |
CA2327685C (en) | 1998-04-03 | 2008-11-18 | Bm Research A/S | Controlled release composition |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
AU2003275953A1 (en) | 2002-11-08 | 2004-06-07 | Egalet A/S | Controlled release carvedilol compositions |
DE602004031096D1 (de) | 2003-03-26 | 2011-03-03 | Egalet As | Morphin-system mit kontrollierter freisetzung |
WO2004084869A1 (en) | 2003-03-26 | 2004-10-07 | Egalet A/S | Matrix compositions for controlled delivery of drug substances |
WO2006030402A2 (en) * | 2004-09-17 | 2006-03-23 | Ranbaxy Laboratories Limited | Dual compartment osmotic delivery device |
ATE413864T1 (de) * | 2005-01-27 | 2008-11-15 | Alza Corp | Orale osmotische darreichungsform mit membran mit hoher flussdichte |
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
AU2010211220B2 (en) | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
WO2010149169A2 (en) | 2009-06-24 | 2010-12-29 | Egalet A/S | Controlled release formulations |
MX2014015880A (es) | 2012-07-06 | 2015-08-05 | Egalet Ltd | Composiciones farmaceuticas disuasivas de abuso para liberacion controlada. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4519801A (en) * | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4753802A (en) * | 1986-03-19 | 1988-06-28 | Alza Corporation | Verapamil dosage form |
-
1989
- 1989-12-18 WO PCT/US1989/005670 patent/WO1990008536A1/en active IP Right Grant
- 1989-12-18 EP EP19900901388 patent/EP0455648B1/en not_active Expired - Lifetime
- 1989-12-18 ES ES90901388T patent/ES2054333T3/es not_active Expired - Lifetime
- 1989-12-18 JP JP50159289A patent/JPH04503058A/ja active Pending
- 1989-12-18 AU AU48114/90A patent/AU621182B2/en not_active Ceased
-
1990
- 1990-01-08 CA CA 2007106 patent/CA2007106A1/en not_active Abandoned
- 1990-01-10 GR GR900100015A patent/GR1000419B/el unknown
- 1990-01-26 IE IE29690A patent/IE61872B1/en not_active IP Right Cessation
- 1990-01-29 ES ES9000257A patent/ES2026304A6/es not_active Expired - Fee Related
- 1990-01-29 DK DK23790A patent/DK23790A/da not_active Application Discontinuation
- 1990-01-29 PT PT9299490A patent/PT92994B/pt not_active IP Right Cessation
-
1991
- 1991-07-29 FI FI913608A patent/FI913608A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4811490A (en) | 1990-08-24 |
IE900296L (en) | 1990-07-30 |
AU621182B2 (en) | 1992-03-05 |
WO1990008536A1 (en) | 1990-08-09 |
EP0455648A1 (en) | 1991-11-13 |
DK23790A (da) | 1990-07-31 |
CA2007106A1 (en) | 1990-07-30 |
DK23790D0 (da) | 1990-01-29 |
GR900100015A (en) | 1991-06-07 |
IE61872B1 (en) | 1994-11-30 |
ES2054333T3 (es) | 1994-08-01 |
ES2026304A6 (es) | 1992-04-16 |
PT92994B (pt) | 1995-12-29 |
FI913608A0 (fi) | 1991-07-29 |
PT92994A (pt) | 1990-07-31 |
JPH04503058A (ja) | 1992-06-04 |
EP0455648B1 (en) | 1993-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO306377B1 (no) | Doseform for avgivelse av et medikament | |
DK0600079T3 (da) | Oral 1alpha-hydroxyprævitamin D | |
FI920956A0 (fi) | Doseringsform foer administrering av oral hypoglykemisk glipisid. | |
GR1000419B (el) | Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. | |
EP0552256A4 (el) | ||
GR1000465B (el) | Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος. | |
MX9700081A (es) | Composiciones farmaceuticas de tacrina. | |
FI925342A (fi) | Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi | |
IT9022471A0 (it) | Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente | |
NZ336055A (en) | An oral sustained release formulation of opioids | |
WO1994027589A3 (en) | Antidepressant dosage form | |
DK0459666T3 (da) | Lægemidler mod impotens | |
HU883863D0 (en) | Process for the preparation of producing and/or portionly form of therapeutical agents | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
IT1235153B (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento | |
UA19756A1 (uk) | Спосіб одержаhhя піперазиhілалкіл-3(2h)піридазиhоhів або їх фармацевтичhо прийhятих солей | |
ATE82120T1 (de) | Kalziumzusaetze. | |
ES2108680T3 (es) | Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento. | |
ATE59550T1 (de) | Chlorpheniramine therapie. | |
NO912497L (no) | Doseringsform for administrering av kalsiumantagonist. | |
GB8808995D0 (en) | Apparatus for oral administration of medicament | |
TH19526A (th) | วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน | |
IT8903497A0 (it) | Somministrazione di miscele gassoseper uso terapeutico o medicinale ingenere | |
IT8748222A0 (it) | Tropina da solo o in combinazione uso di un medicamento a base di un con l'ormone follicolo-stimolante fattore di rilascio della somatonel trattamento della sterilita |